Lauxera Capital Partners
Overview
Healthcare-focused asset management company investing in growth equity.
Founded
2020
Deals · 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Bridge to Life | Aug 2026Participated | $110 MSeries C | |
OrganOx | Feb 2025Participated | $142 MOther Equity | |
Caresyntax | Aug 2024Participated | $180 MDebt | |
Natural Cycles | May 2024Led | $55 MSeries C | |
BioLamina | Sep 2023Led | $18 MOther Equity | |
OrganOx | Jul 2023Led | $33 MOther Equity | |
Lifen | Nov 2021Led | $57 MSeries C | |
Caresyntax | Sep 2021Participated | $30 MSeries C | |
Caresyntax | Apr 2021Participated | $100 MSeries C | |
LUMICKS | Apr 2021Led | $93 MSeries D | |
Bridge to Life | Aug 2026Participated | $110 MSeries C | |
OrganOx | Feb 2025Participated | $142 MOther Equity | |
Caresyntax | Aug 2024Participated | $180 MDebt | |
Natural Cycles | May 2024Led | $55 MSeries C | |
BioLamina | Sep 2023Led | $18 MOther Equity | |
OrganOx | Jul 2023Led | $33 MOther Equity | |
Lifen | Nov 2021Led | $57 MSeries C | |
Caresyntax | Sep 2021Participated | $30 MSeries C | |
Caresyntax | Apr 2021Participated | $100 MSeries C | |
LUMICKS | Apr 2021Led | $93 MSeries D |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series C+ | 3 | 3 |
| Other Equity | 2 | 1 |
| Debt | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '21 | 2 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 10 |
| Enterprise Software | 4 |
| AI & Machine Learning | 3 |
| Data, Analytics & IT | 3 |
| Hardware & Robotics | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 2 |
| $50M-$100M | 3 |
| $100M-$250M | 4 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 6 |
| United States | 4 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Optum Ventures | 3 |
| Relyens Group | 3 |
| Vesalius Biocapital | 3 |
| Arno Capital | 2 |
| Intel Capital | 2 |
| IPF Partners | 2 |
| PFM Health Sciences | 2 |
| ProAssurance | 2 |
| Rezayat Investments | 2 |
| Soleus Capital | 2 |
| surgical.ai | 2 |
| Aescuvest | 1 |
| Avidity Partners | 1 |
| BGF | 1 |
| BIONIQ Capital | 1 |
| BlackRock | 1 |
| BlackRock Innovation Capital | 1 |
| Bonnier Ventures | 1 |
| Bure | 1 |
| Creadev | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 50% |
| Participating | 5 | 50% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 60% |
| Co-led | 2 | 40% |